Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
NVNI | NVNI Group Ltd | 4.38 | 2.89 | 193.96% | 366,976,554 |
EVAX | Evaxion Biotech AS | 5.99 | 2.35 | 64.56% | 55,411,545 |
ELAB | PMGC Holdings Inc | 3.0901 | 1.11 | 56.07% | 76,479,886 |
PCLA | PicoCELA Inc | 4.60 | 1.52 | 49.35% | 3,747,286 |
GOEV | Canoo Inc | 0.475 | 0.145 | 43.94% | 282,223,189 |
FMST | Foremost Clean Energy Ltd | 1.875 | 0.455 | 32.04% | 1,278,200 |
LTRN | Lantern Pharma Inc | 5.448 | 1.28 | 30.65% | 1,483,991 |
RNAZ | TransCode Therapeutics Inc | 7.17 | 1.67 | 30.36% | 12,664,567 |
ACON | Aclarion Inc | 0.0557 | 0.0125 | 28.94% | 811,914,644 |
NDLS | Noodles and Company | 1.38 | 0.29 | 26.61% | 775,379 |
DPRO | Draganfly Inc | 3.70 | 0.73 | 24.58% | 690,679 |
SHANGHAI, Jan. 24, 2025 /PRNewswire/ -- Gamehaus Holdings Inc. ("Gamehaus" or the "Company"), a technology-driven mobile game publishing company, and Golden Star Acquisition Corporation (NASDAQ: GODN) ("Golden Star"), a publicly-traded special purpose acquisition company, today announced the completion of their previously announced business combination. The business combination was approved at an extraordinary general meeting of Golden Star's shareholders on January 20, 2025. Gamehaus' Class A ordinary shares will commence trading on the Nasdaq Capital Market ("Nasdaq") under the ticker symbol "GMHS" beginning Monday, January 27, 2025.
SHANGHAI, Jan. 24, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that it has entered into a securities purchase agreement with certain institutional investors to sell 1,041,668 Class A ordinary shares (or pre-funded warrants in lieu thereof) of the Company in a registered direct offering. In a concurrent private placement, the Company also agreed to issue and sell to the investors warrants to purchase up to 1,562,502 Class A ordinary shares. The combined effective ...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has extended its 13-year relationship with Tigermed, a leading global provider of clinical research solutions across the full life cycle of global biopharmaceutical and medical device products. This extended partnership will further harness the Medidata Platform from early-phase trials to post-marketing surveillance, to optimize study workflows, ensure regulatory compliance, and improve the speed of delivering new therapies to patients worldwide, including the emerging markets.
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on January 28, 2025, the Company will implement a 1-for-16 reverse split of its common stock following approval at its Special Meeting of Stockholders held on January 17, 2025. The reverse stock split will be effective as of the morning of January 28, 2025, and the Company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol “REVB.” The CUSIP number for the common stock following the reverse stock split will be 76135L606.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 104,593.80 | -258.60 | -0.25% | 2.07T | 4,252,444,355 |
ETH | Ethereum | 3,305.62 | -4.75 | -0.14% | 397.91B | 2,054,708,803 |
XRP | Ripple | 3.11 | 0.010 | 0.32% | 175.91B | 989,177,107 |
USDT | Tether USD | 0.99984 | -0.00006 | -0.01% | 119.64B | 494,345,326 |
SOL | Solana | 251.13 | -2.26 | -0.89% | 117.56B | 2,028,713,577 |
BNB | Binance Coin | 685.75 | 4.84 | 0.71% | 108.22B | 142,560,376 |
DOGE | Dogecoin | 0.34966 | -0.00106 | -0.30% | 51.15B | 463,946,978 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 35.56B | 1,220,719,775 |
ADA | Cardano | 0.9778 | 0.0058 | 0.60% | 34.89B | 174,874,406 |
STETH | stETH | 3,301.53 | -3.54 | -0.11% | 32.37B | 5,394,221 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions